全文获取类型
收费全文 | 439篇 |
免费 | 42篇 |
国内免费 | 31篇 |
专业分类
儿科学 | 30篇 |
妇产科学 | 1篇 |
基础医学 | 53篇 |
口腔科学 | 8篇 |
临床医学 | 49篇 |
内科学 | 102篇 |
皮肤病学 | 9篇 |
神经病学 | 23篇 |
特种医学 | 78篇 |
外科学 | 21篇 |
综合类 | 16篇 |
预防医学 | 18篇 |
眼科学 | 2篇 |
药学 | 30篇 |
1篇 | |
肿瘤学 | 71篇 |
出版年
2024年 | 1篇 |
2023年 | 2篇 |
2021年 | 3篇 |
2020年 | 3篇 |
2019年 | 10篇 |
2018年 | 8篇 |
2017年 | 5篇 |
2016年 | 15篇 |
2015年 | 16篇 |
2014年 | 14篇 |
2013年 | 20篇 |
2012年 | 13篇 |
2011年 | 16篇 |
2010年 | 20篇 |
2009年 | 13篇 |
2008年 | 16篇 |
2007年 | 35篇 |
2006年 | 19篇 |
2005年 | 20篇 |
2004年 | 15篇 |
2003年 | 9篇 |
2002年 | 13篇 |
2001年 | 9篇 |
2000年 | 12篇 |
1999年 | 9篇 |
1998年 | 22篇 |
1997年 | 17篇 |
1996年 | 15篇 |
1995年 | 16篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 4篇 |
1991年 | 8篇 |
1989年 | 13篇 |
1988年 | 17篇 |
1987年 | 11篇 |
1986年 | 9篇 |
1985年 | 4篇 |
1984年 | 4篇 |
1983年 | 8篇 |
1982年 | 5篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1975年 | 3篇 |
排序方式: 共有512条查询结果,搜索用时 31 毫秒
1.
Anulus fibrosus in bulging intervertebral disks 总被引:1,自引:0,他引:1
In this investigation the association of radial tears of the anulus fibrosus and bulging of the intervertebral disk was studied. An index of disk bulging was measured in sagittal anatomic sections in 149 lumbar disks from 31 cadavers. The indexes of disk bulging were correlated with stages of disk development and the presence of an annular tear. The largest disk-bulging indexes were always associated with radial tears of the anulus. Eighty-four percent of the disks with radial tears had disk-bulging indexes greater than 2.5 mm. Most normal adult disks had an index of less than 2.5 mm. The results challenge the concept that the anulus fibrosus is intact in bulging disks, although ruptured in herniated disks. 相似文献
2.
3.
4.
Cassandra A Slader l Helen K Reddel Sinthia Z Bosnic-Anticevich 《The Journal of asthma》2004,41(3):367-373
BACKGROUND: Chlorofluorocarbon (CFC)-free metered-dose inhalers (MDIs) were introduced into Australia in 1999. Device care instructions were modified (e.g., CFC-free salbutamol inhalers to be washed weekly), but this information was not communicated directly to health care professionals. OBJECTIVE: This pilot study aimed to assess the level of awareness of device care protocols for CFC-free MDIs by patients and their pharmacists. SETTING AND DESIGN: Purchasers of CFC-free MDIs were recruited from four community pharmacies. They were interviewed regarding information sources, knowledge of propellant change, and awareness of and adherence to device care protocols. The dispensing pharmacists were interviewed for knowledge of CFC-free device care. The primary outcome variable was awareness of the relevant device care protocol. RESULTS: Thirty-nine patients were interviewed. Most patients (77%) were aware of the change to CFC-free propellant. Only nine patients (23%) were aware of the need to wash the device holder, and four patients (10% of total) complied with the specified protocol. One of the ten dispensing pharmacists could describe correct device care protocols for the CFC-free MDIs. CONCLUSIONS: Although most patients are aware that MDIs are now CFC-free, there is a low level of awareness of the device care required for these inhalers, and a very low rate of compliance with recommended practice. Although the clinical impact of failing to wash the device holder is unclear, this added instruction may have substantial implications for patient satisfaction and medication delivery. Pharmaceutical manufacturers need to highlight to health care professionals any clinically important changes in device care instructions, so that appropriate information may be passed on to patients. 相似文献
5.
6.
7.
Anti-GQ1b antibodies are typically found in patients with the Miller Fisher syndrome, all of whom will have, by definition, acute ophthalmoplegia. The authors describe three patients with chronic ophthalmoplegia in the presence of persistently high titers of immunoglobulin G anti-GQ1b antibody detected in an ELISA, one of whom improved with immunotherapy. Anti-GQ1b antibodies may be associated with some cases of chronic ophthalmoplegia of unknown cause. 相似文献
8.
Early stage nasopharyngeal carcinoma: radiotherapy dose and time factors in tumor control 总被引:1,自引:0,他引:1
Chang JT; See LC; Liao CT; Chen LH; Leung WM; Chen SW; Chen WC 《Japanese journal of clinical oncology》1998,28(3):207-213
OBJECTIVE: To evaluate radiotherapy dose and length of treatment in the
control of early stage nasopharyngeal carcinoma (NPC) treated with a
combination of external radiotherapy and brachytherapy, MATERIALS &
METHODS: We reviewed the records of 133 patients with early stage
nasopharyngeal carcinoma (stage I or II, AJC/UICC staging system) who
received definitive radiotherapy in Chang Gung Memorial Hospital from 1979
to 1991. The median follow-up time was 7.1 years with a minimum of 2 years.
All patients were treated with megavoltage external radiotherapy to the
nasopharynx area (63-72 Gy) followed by high dose rate intracavitary
brachytherapy (5-16.5 Gy in one to three fractions, spaced 1-2 weeks
apart). The median total dose and time of irradiation was 75 Gy (69.8-81.4
Gy) and 11.6 weeks (7.8-20 weeks) respectively. Survival analysis was used
to examine the effect of several variables on prognosis. RESULTS: The
5-year rates were 86.4% for local control, 84.7% for disease free survival,
88.5% for actuarial survival and 84.2% for overall survival. The treatment
group (combination of time and dose of irradiation) was the most important
prognostic factor according to Cox's proportional hazard model. Patients
receiving radiation at a total dose of < or = 75 Gy completed in < 12
weeks showed the best prognosis. CONCLUSION: Treatment time and total
treatment dose are both important factors in treating early stage NPC.
Decreasing the total radiation time to < 12 weeks and not exceeding a
radiation dose of 75 Gy gave the best results.
相似文献
9.
S. A. Hiles E. S. Harvey V. M. McDonald M. Peters P. Bardin P. N. Reynolds J. W. Upham M. Baraket Z. Bhikoo J. Bowden B. Brockway L. P. Chung B. Cochrane G. Foxley J. Garrett M. Hew L. Jayaram C. Jenkins C. Katelaris G. Katsoulotos M. S. Koh V. Kritikos M. Lambert D. Langton A. Lara Rivero G. B. Marks P. G. Middleton A. Nanguzgambo N. Radhakrishna H. Reddel J. Rimmer A. M. Southcott M. Sutherland F. Thien P. A. B. Wark I. A. Yang E. Yap P. G. Gibson 《Clinical and experimental allergy》2018,48(6):650-662
10.